- Research article
- Open Access
Analysis of a β-helical region in the p55 domain of Helicobacter pylori vacuolating toxin
© Ivie et al; licensee BioMed Central Ltd. 2010
Received: 7 December 2009
Accepted: 23 February 2010
Published: 23 February 2010
Helicobacter pylori is a gram-negative bacterium that colonizes the human stomach and contributes to the development of gastric cancer and peptic ulcer disease. VacA, a toxin secreted by H. pylori, is comprised of two domains, designated p33 and p55. Analysis of the crystal structure of the p55 domain indicated that its structure is predominantly a right-handed parallel β-helix, which is a characteristic of autotransporter passenger domains. Substitution mutations of specific amino acids within the p33 domain abrogate VacA activity, but thus far, it has been difficult to identify small inactivating mutations within the p55 domain. Therefore, we hypothesized that large portions of the p55 domain might be non-essential for vacuolating toxin activity. To test this hypothesis, we introduced eight deletion mutations (each corresponding to a single coil within a β-helical segment spanning VacA amino acids 433-628) into the H. pylori chromosomal vacA gene.
All eight of the mutant VacA proteins were expressed by the corresponding H. pylori mutant strains and underwent proteolytic processing to yield ~85 kDa passenger domains. Three mutant proteins (VacA Δ484-504, Δ511-536, and Δ517-544) were secreted and induced vacuolation of mammalian cells, which indicated that these β-helical coils were dispensable for vacuolating toxin activity. One mutant protein (VacA Δ433-461) exhibited reduced vacuolating toxin activity compared to wild-type VacA. Other mutant proteins, including those containing deletions near the carboxy-terminal end of the β-helical region (amino acids Val559-Asn628), exhibited marked defects in secretion and increased susceptibility to proteolytic cleavage by trypsin, which suggested that these proteins were misfolded.
These results indicate that within the β-helical segment of the VacA p55 domain, there are regions of plasticity that tolerate alterations without detrimental effects on protein secretion or activity, as well as a carboxy-terminal region in which similar alterations result in protein misfolding and impaired secretion. We propose that non-essential β-helical coils and a carboxy-terminal β-helical segment required for proper protein folding and secretion are features shared by numerous autotransporter passenger domains.
Numerous bacterial pathogens secrete virulence factors by a type V (autotransporter) pathway . Crystallographic studies of three passenger domains secreted by a classical (type Va) autotransporter pathway revealed that each has a predominantly β-helical structure [2–4], and it is predicted that nearly all autotransporter passenger domains share a β-helical fold . Very little is known about the structural features that are responsible for the unique properties of individual autotransporter passenger domains.
The Helicobacter pylori VacA toxin is one of the most extensively studied bacterial proteins secreted by a classical autotransporter pathway [6–9]. VacA is classified as a pore-forming toxin, but unlike many other bacterial pore-forming toxins, VacA is internalized by cells and can cause cellular alterations by acting intracellularly [6, 7, 10]. VacA causes a wide array of alterations in mammalian cells, including cell vacuolation, mitochondrial alterations, and plasma membrane permeabilization [6, 8], and targets a variety of cell types, including gastric epithelial cells , T cells [12, 13], and mast cells [14, 15]. Several lines of evidence suggest that VacA contributes to the development of H. pylori-associated peptic ulcer disease and gastric adenocarcinoma in humans [6, 11, 16–18].
Recently the crystal structure of the p55 domain of a VacA protein was determined . The most striking feature of this domain is the presence of a right-handed parallel β-helical structure, composed of coiled, parallel β-sheet structures (Fig. 1B). Each coil of the parallel β-helix consists of three parallel β-strands connected by loops of different lengths. The β-helical portion of the VacA p55 domain of H. pylori strain 60190 consists of about 13 coils (Fig. 1B) . Substitution mutagenesis of single amino acids within the amino-terminal region of the p33 domain is sufficient to ablate multiple activities of VacA [24–27], but in contrast, it has been difficult to identify small inactivating mutations within the p55 domain . The only known small inactivating mutation within the p55 domain is a deletion of two amino acids (aspartic acid 346 and glycine 347, located in a region of the p55 domain not included in the crystal structure) [29, 32], which results in defective oligomerization of VacA.
Since it has been difficult to identify small inactivating mutations within the p55 domain , we hypothesized that large portions of the p55 domain might be non-essential for vacuolating toxin activity. To test this hypothesis, in the current study we generated a set of H. pylori mutant strains expressing VacA proteins in which individual coils of the p55 β-helix were deleted, and we then analyzed the secretion and activity of these mutant proteins. We report that within the VacA β-helix, there are regions of plasticity that tolerate alterations without detrimental effects on protein secretion or activity, as well as a carboxy-terminal region in which similar alterations result in impaired secretion and protein misfolding.
H. pylori strains and growth conditions
H. pylori wild-type strain 60190 (ATCC 49503) was the parent strain used for construction of all mutants in this study. The sequence of the VacA protein encoded by this strain is deposited as GenBank accession number Q48245. Throughout this study, we use an amino acid numbering system in which residue 1 refers to alanine 1 of the secreted 88 kDa VacA protein, and the p55 domain corresponds to amino acids 312 to 821. H. pylori strains were grown on trypticase soy agar plates containing 5% sheep blood at 37°C in ambient air containing 5% CO2. H. pylori liquid cultures were grown in sulfite-free Brucella broth containing 10% fetal bovine serum (BB-FBS).
Introduction of deletion mutations into the chromosomal vacA gene of H. pylori
To introduce in-frame internal deletion mutations into a plasmid encoding VacA, we performed inverse PCR using pMM592 (encoding wild-type VacA, amino acids 1 to 821)  as template DNA, 5'-phosphorylated primers, and Pfu Turbo polymerase (Stratagene). The resulting PCR products were then ligated and transformed into E. coli DH5α. Each plasmid was analyzed by DNA sequencing to verify that the desired deletion was present. To introduce the mutations into the H. pylori chromosomal vacA gene [25, 34, 35], H. pylori strains containing a sacB-kanamycin cassette within vacA  were transformed with plasmids containing vacA deletion mutations. Three strains (VM025, VM018, and VM028), each derived from H. pylori strain 60190 and each containing the sacB-kanamycin cassette in a different site within vacA , were used to facilitate construction of the desired mutants. Sucrose-resistant, kanamycin-sensitive transformants were selected by growth on Brucella broth plates supplemented with 10% FBS and 5.5% sucrose . Full-length vacA sequences encoding the secreted p88 VacA protein were PCR-amplified from mutant strains, and the nucleotide sequences of PCR products were analyzed to confirm that the desired mutation had been introduced successfully into the chromosomal vacA gene.
Immunoblot analysis of VacA
To detect VacA expression, proteins in individual samples were separated by SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose membrane, and immunoblotted using a polyclonal rabbit anti-VacA antiserum (#958) raised against the secreted 88 kDa passenger domain , followed by horseradish peroxidase-labeled rabbit IgG. Peptide mapping experiments, using a set of overlapping 16-amino-acid peptides derived from VacA, indicate that the polyclonal anti-VacA antiserum #958 reacts with at least 10 different epitopes distributed throughout the secreted 88 kDa VacA protein, including the amino-terminus (amino acids 1-16) and the carboxy-terminus (amino acids 813-828) (our unpublished data). To confirm similar loading of lysates from wild-type and mutant H. pylori strains, the lysates were immunoblotted with rabbit antiserum to HspB (a GroEL heat shock protein homolog) . The anti-HspB serum was also used to detect the potential release of HspB into culture supernatant by autolysis. Signals were generated by the enhanced chemiluminescence reaction and detected using x-ray film.
Preparation of broth culture supernatants and normalization of VacA concentrations
H. pylori strains were grown in BB-FBS for 48 hours. Broth culture supernatants were concentrated 30-fold by ultrafiltration with a 30 kDa cutoff membrane. Relative concentrations of VacA in different broth culture supernatant preparations were determined by antigen-detection ELISA . Broth culture supernatants were diluted in carbonate buffer (18 mM Na2CO3, 34.8 mM NaHCO3) and allowed to adhere to an ELISA plate overnight at room temperature. After removal of unbound VacA proteins, wells were blocked with phosphate buffered saline (PBS) containing 3% BSA and 0.05% Tween 20. VacA was detected with rabbit anti-VacA antiserum (#958) and horseradish peroxidase-labeled rabbit IgG followed by TMB substrate (Pierce). To permit normalization of VacA concentrations in different preparations, samples were diluted with appropriate quantities of culture supernatant from a vacA null mutant strain, based on the antigen-detection ELISA results.
Sonication of H. pylori
H. pylori grown on blood agar plates were suspended in sonication buffer [20 mM Tris-acetate (pH 7.9), 50 mM potassium acetate, 5 mM Na2EDTA, 1 mM dithiothreitol (DTT), protease inhibitor cocktail] and sonicated on ice for three 10 second pulses. The lysate was centrifuged at 15,000 rpm and the supernatant collected.
Susceptibility of VacA to proteolysis by trypsin
H. pylori grown on blood agar plates were suspended in phosphate buffered saline (PBS), and bacterial suspensions were treated with trypsin (0.05%) for 30 min at 37°C. After addition of a protease inhibitor cocktail, the bacteria were pelleted, and the pellet washed once with PBS containing protease inhibitor. The pellet was then suspended in SDS lysis buffer, boiled, and analyzed by immunoblot. Sonicated preparations of H. pylori were treated with trypsin and analyzed in the same manner.
Analysis of VacA reactivity with a monoclonal antibody
Concentrated culture supernatants containing different VacA mutant proteins were adjusted so that the VacA concentrations were normalized, and then were diluted in carbonate buffer and allowed to adhere to an ELISA plate overnight at room temperature. After removal of unbound VacA proteins, wells were blocked with phosphate buffered saline (PBS) containing 3% BSA and 0.05% Tween 20. VacA was detected with mouse anti-VacA (5E4)  and horseradish peroxidase-labeled mouse IgG followed by TMB substrate (Pierce).
Cell culture analysis of VacA proteins
HeLa cells were grown as described previously . AZ-521 cells (a human gastric adenocarcinoma cell line, Culture Collection of Health Science Research Resources Bank, Japan Health Sciences Foundation) and RK13 cells (ATCC CCL-37, a rabbit kidney cell line) were grown in minimal essential medium supplemented with 10% FBS and 1 mM non-essential amino acids. For vacuolating assays, cells were seeded at 2 × 104 cells/well into 96-well plates 24 hours prior to each experiment. The VacA content of different samples was normalized as described above. Serial dilutions of samples were added to serum-free tissue culture medium overlying cells (supplemented with 5 mM ammonium chloride) and incubated for 8-10 hours at 37°C. An equivalent volume of a corresponding preparation from a vacA null mutant was used as a negative control. After incubation, cell vacuolation was examined by inverted light microscopy and quantified by a neutral red uptake assay . Neutral red uptake data are presented as A540 values (mean ± S.D.). Background levels of neutral red uptake by cells treated with culture supernatant from a vacA null mutant were subtracted to yield net neutral red uptake values.
Expression and secretion of mutant VacA proteins by H. pylori
The structure of the VacA p55 domain is dominated by β-helical coils . In previous studies, it has been difficult to identify specific amino acids within the p55 domain that are important for toxin activity . To determine whether specific β-helical elements within the VacA p55 domain are required for VacA activity, we introduced an ordered series of eight deletion mutations, each 20 to 28 amino acids in length, into a portion of the vacA gene that encodes the p55 domain. These deletion mutations were designed so that each would result in the deletion of a single coil of the β-helix (Fig. 1A; representative single coils are highlighted in Fig. 1B). By designing the deletion mutations in this manner, it was predicted that the mutant proteins would exhibit reductions in the length of the β-helical region but would exhibit minimal changes in protein folding in comparison to the wild-type VacA protein. All of the deletion mutations analyzed in this study are located outside of the VacA region (amino acids 1-422) previously found to be required for cell vacuolation when VacA is expressed in transiently transfected cells . Each of the mutations was introduced into the H. pylori chromosomal vacA gene by natural transformation and allelic exchange as described in Methods.
Susceptibility of VacA mutant proteins to proteolytic cleavage by trypsin
To analyze potential differences in folding properties of the VacA mutant proteins compared to wild-type VacA, we analyzed the susceptibility of these proteins to proteolytic cleavage. Lysates of H. pylori strains were generated by sonication, and the solubilized proteins were treated with trypsin as described in Methods. Trypsin digestion of two of the mutant proteins (Δ511-536 and Δ517-544) yielded proteolytic digest patterns that were identical to each other and similar to that of trypsin-digested wild-type VacA (Fig. 3B). Trypsin digestion of two other mutant proteins (Δ433-461 and Δ484-504) yielded different digest patterns, but these mutant proteins were not completely degraded (Fig. 3B). Four mutant proteins (Δ462-483, Δ559-579, Δ580-607, and Δ608-628) were completely degraded by trypsin (Fig. 3B). In general, the four mutant proteins that exhibited relative resistance to trypsin digestion were secreted at relatively high levels compared to mutant proteins that were completely degraded by trypsin (compare Fig. 2 and Fig. 3B). The observed variation among mutant VacA proteins in susceptibility to trypsin-mediated proteolysis suggested that the individual mutant proteins differed in folding properties. The proteins that were highly susceptible to trypsin digestion and secreted at very low levels (Δ462-483, Δ559-579, Δ580-607, and Δ608-628) were probably misfolded. Due to the very low concentrations of these four proteins in the broth culture supernatants, these mutant VacA proteins were not studied further.
Analysis of vacuolating activity of mutant VacA proteins
We next investigated whether the mutant VacA proteins retained vacuolating toxin activity. As a first approach, we attempted to purify the mutant VacA proteins from H. pylori broth culture supernatants, using methods that are well-established for purification of water-soluble oligomeric forms of wild-type VacA or mutant VacA proteins that contain alterations in the p33 domain [26, 34, 36]. We focused these purification efforts on the four mutant proteins that were secreted at the highest levels and that exhibited evidence of protein folding similar to that of wild-type VacA (i.e. VacA Δ433-461, Δ484-504, Δ511-536, and Δ517-544). The yields of purified mutant proteins were markedly lower than yields of purified wild-type VacA, and several of the VacA mutant proteins were not successfully purified. These results could be attributable to relative defects in oligomerization of mutant proteins compared to wild-type VacA, or could be attributable to other altered properties of the mutant proteins that resulted in aberrant behavior during the purification procedure.
In this study, we sought to identify regions of the p55 β-helix that are either essential or non-essential for vacuolating toxin activity. All of the VacA mutant proteins analyzed in this study were designed in a manner that resulted in the deletion of a single coil of the β-helix, based on analysis of the crystal structure of the VacA p55 domain . We predicted that all of the mutant VacA proteins would retain a β-helical structure, and that this mutagenesis approach would result in minimal disruptions in protein folding.
As a first step, we analyzed the proteolytic processing and secretion of the mutant proteins. All eight of the mutant VacA proteins were expressed by the corresponding H. pylori mutant strains and underwent proteolytic processing to yield ~85 kDa passenger domains. We found that several individual coils within the p55 domain could be deleted without substantially altering the capacity of the proteins to undergo secretion by H. pylori. In contrast, the deletion of other coils led to a marked defect in VacA secretion. The mutant proteins that exhibited marked defects in secretion also exhibited increased susceptibility to proteolytic cleavage by trypsin, which suggested that these proteins were misfolded. In addition to the mutant VacA proteins shown in Figure 1, we also generated H. pylori mutant strains expressing VacA proteins in which two coils (Δ433-483) or four coils (Δ433-529) of the β-helix were deleted. These mutant strains expressed truncated VacA proteins of the expected size (approximately 82 and 77 kDa, respectively) at levels similar to the level of wild-type VacA expression, but these mutant proteins were poorly secreted (data not shown). These findings suggest that VacA proteins containing large deletions (more than one coil) within the β-helical region of the p55 domain are poorly secreted. Similarly, a previous study reported efforts to introduce large deletions into the region of the H. pylori chromosomal vacA gene that encodes the VacA p55 domain, and most of the resulting mutant proteins were neither expressed nor secreted by H. pylori .
In the current study, the three mutant VacA proteins that exhibited the most striking defects in secretion (Δ559-579, Δ580-607, Δ608-628) each contained deletions that are localized near the carboxy-terminus of the β-helix. Interestingly, a study of Bordetella pertussis BrkA revealed that a β-helical region near the carboxy-terminus of the passenger domain is required for folding of this protein . The authors proposed that this domain acts as an intramolecular chaperone to promote folding of the passenger domain concurrent with or following translocation through the outer membrane. Similarly, studies of B. pertussis pertactin indicate that the carboxy-terminal β-helical region of this protein exhibits enhanced stability and can fold as a stable core structure [5, 45]. We speculate that VacA amino acids 559-628 have a similar functional role in promoting protein folding and secretion.
An important finding in the current study is that, within the VacA β-helix, there are regions of plasticity that tolerate alterations without detrimental effects on protein secretion or toxin activity. VacA Δ484-504, Δ511-536, and Δ517-544 mutant proteins each retained vacuolating activity similar to that of wild-type VacA, which indicates that the corresponding coils are dispensable for vacuolating toxin activity. The retention of vacuolating activity despite the deletion of entire coils of the β-helix correlates well with results from a previous study, which reported that inactivating point mutations within the portion of vacA encoding the p55 domain could not be identified . One of the VacA mutant proteins analyzed in the current study (Δ433-461) exhibited detectable vacuolating toxin activity on HeLa cells, but its activity on HeLa cells was reduced compared to that of wild-type VacA, and it lacked detectable activity on RK13 cells and AZ521 cells. These data suggest that residues within this VacA region (amino acids 433-461) have an important role in VacA activity. Further studies may lead to the identification of specific amino acids within this region that mediate interactions between VacA and host cells. Similar to most previous studies, the current study assessed the effects of VacA mutations on the ability of VacA to cause cell vacuolation. Future investigations may provide new insights into structural properties of VacA that are required for other actions of this multifunctional toxin.
VacA is a unique toxin that is considered to be an important determinant of H. pylori virulence, and therefore, it is important to have an in-depth understanding of VacA structure and function. The VacA p55 structure is predominantly a right-handed parallel β-helix, which is a characteristic of autotransporter passenger domains. Previous studies suggested that the p55 domain contributes to VacA binding to cells, but it has been difficult to identify small inactivating mutations within the p55 domain. Therefore, we hypothesized that large segments of the p55 domain might be non-essential for vacuolating toxin activity. To test this hypothesis, we constructed and analyzed a set of H. pylori mutant strains expressing VacA proteins in which individual coils of the beta-helix were deleted. Three mutant proteins containing deletions in the region spanning VacA amino acids 484-544 were efficiently secreted and induced vacuolation of mammalian cells, which indicates that these segments are dispensable for vacuolating toxin activity. We also identified a region near the carboxy-terminal end of the β-helix (amino acids 559-628), in which the introduction of similar deletion mutations resulted in marked defects in protein secretion and apparent defects in protein folding. We propose that non-essential β-helical coils and a carboxy-terminal β-helical segment required for proper protein folding and secretion are features of numerous autotransporter passenger domains.
This work was supported by the National Institutes of Health (R01 AI039657) (TC), the Department of Veterans Affairs (TC) and the Burroughs Wellcome Fund (DBL).
- Dautin N, Bernstein HD: Protein secretion in gram-negative bacteria via the autotransporter pathway. Annu Rev Microbiol. 2007, 61: 89-112. 10.1146/annurev.micro.61.080706.093233.View ArticlePubMedGoogle Scholar
- Emsley P, Charles IG, Fairweather NF, Isaacs NW: Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature. 1996, 381: 90-92. 10.1038/381090a0.View ArticlePubMedGoogle Scholar
- Gangwer KA, Mushrush DJ, Stauff DL, Spiller B, McClain MS, Cover TL, Lacy DB: Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc Natl Acad Sci USA. 2007, 104: 16293-16298. 10.1073/pnas.0707447104.PubMed CentralView ArticlePubMedGoogle Scholar
- Otto BR, Sijbrandi R, Luirink J, Oudega B, Heddle JG, Mizutani K, Park SY, Tame JR: Crystal structure of hemoglobin protease, a heme binding autotransporter protein from pathogenic Escherichia coli. J Biol Chem. 2005, 280: 17339-17345. 10.1074/jbc.M412885200.View ArticlePubMedGoogle Scholar
- Junker M, Schuster CC, McDonnell AV, Sorg KA, Finn MC, Berger B, Clark PL: Pertactin beta-helix folding mechanism suggests common themes for the secretion and folding of autotransporter proteins. Proc Natl Acad Sci USA. 2006, 103: 4918-4923. 10.1073/pnas.0507923103.PubMed CentralView ArticlePubMedGoogle Scholar
- Cover TL, Blanke SR: Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol. 2005, 3: 320-332. 10.1038/nrmicro1095.View ArticlePubMedGoogle Scholar
- Fischer W, Buhrdorf R, Gerland E, Haas R: Outer membrane targeting of passenger proteins by the vacuolating cytotoxin autotransporter of Helicobacter pylori. Infect Immun. 2001, 69: 6769-6775. 10.1128/IAI.69.11.6769-6775.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Gebert B, Fischer W, Haas R: The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol. 2004, 152: 205-220. full_text.PubMedGoogle Scholar
- Montecucco C, Rappuoli R: Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol. 2001, 2: 457-466. 10.1038/35073084.View ArticlePubMedGoogle Scholar
- Gauthier NC, Monzo P, Gonzalez T, Doye A, Oldani A, Gounon P, Ricci V, Cormont M, Boquet P: Early endosomes associated with dynamic F-actin structures are required for late trafficking of H. pylori VacA toxin. J Cell Biol. 2007, 177: 343-354. 10.1083/jcb.200609061.PubMed CentralView ArticlePubMedGoogle Scholar
- Fujikawa A, Shirasaka D, Yamamoto S, Ota H, Yahiro K, Fukada M, Shintani T, Wada A, Aoyama N, Hirayama T: Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet. 2003, 33: 375-381. 10.1038/ng1112.View ArticlePubMedGoogle Scholar
- Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R: Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 2003, 301: 1099-1102. 10.1126/science.1086871.View ArticlePubMedGoogle Scholar
- Sundrud MS, Torres VJ, Unutmaz D, Cover TL: Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA. 2004, 101: 7727-7732. 10.1073/pnas.0401528101.PubMed CentralView ArticlePubMedGoogle Scholar
- de Bernard M, Cappon A, Pancotto L, Ruggiero P, Rivera J, Del Giudice G, Montecucco C: The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations. Cell Microbiol. 2005, 7: 191-198.View ArticlePubMedGoogle Scholar
- Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C: Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol. 2002, 168: 2603-2607.View ArticlePubMedGoogle Scholar
- Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995, 270: 17771-17777. 10.1074/jbc.270.30.17771.View ArticlePubMedGoogle Scholar
- Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ: Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002, 94: 1680-1687.View ArticlePubMedGoogle Scholar
- Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, Tecce MF, Censini S, Covacci A, Xiang Z: Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med. 1994, 179: 1653-1658. 10.1084/jem.179.5.1653.View ArticlePubMedGoogle Scholar
- Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ: Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem. 1994, 269: 10566-10573.PubMedGoogle Scholar
- Schmitt W, Haas R: Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol. 1994, 12: 307-319. 10.1111/j.1365-2958.1994.tb01019.x.View ArticlePubMedGoogle Scholar
- Nguyen VQ, Caprioli RM, Cover TL: Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect Immun. 2001, 69: 543-546. 10.1128/IAI.69.1.543-546.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Torres VJ, Ivie SE, McClain MS, Cover TL: Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin. J Biol Chem. 2005, 280: 21107-21114. 10.1074/jbc.M501042200.View ArticlePubMedGoogle Scholar
- Torres VJ, McClain MS, Cover TL: Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA). J Biol Chem. 2004, 279: 2324-2331. 10.1074/jbc.M310159200.View ArticlePubMedGoogle Scholar
- Ye D, Willhite DC, Blanke SR: Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J Biol Chem. 1999, 274: 9277-9282. 10.1074/jbc.274.14.9277.View ArticlePubMedGoogle Scholar
- McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, Shao Z, Cover TL: A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol. 2001, 183: 6499-6508. 10.1128/JB.183.22.6499-6508.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- McClain MS, Czajkowsky DM, Torres VJ, Szabo G, Shao Z, Cover TL: Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity. Infect Immun. 2006, 74: 6188-6195. 10.1128/IAI.00915-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Ye D, Blanke SR: Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation. Infect Immun. 2000, 68: 4354-4357. 10.1128/IAI.68.7.4354-4357.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Genisset C, Galeotti CL, Lupetti P, Mercati D, Skibinski DA, Barone S, Battistutta R, de Bernard M, Telford JL: A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype. Infect Immun. 2006, 74: 1786-1794. 10.1128/IAI.74.3.1786-1794.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Ivie SE, McClain MS, Torres VJ, Algood HM, Lacy DB, Yang R, Blanke SR, Cover TL: Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes. Infect Immun. 2008, 76: 2843-2851. 10.1128/IAI.01664-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Garner JA, Cover TL: Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infect Immun. 1996, 64: 4197-4203.PubMed CentralPubMedGoogle Scholar
- Wang HJ, Wang WC: Expression and binding analysis of GST-VacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells. Biochem Biophys Res Commun. 2000, 278: 449-454. 10.1006/bbrc.2000.3820.View ArticlePubMedGoogle Scholar
- Ye D, Blanke SR: Functional complementation reveals the importance of intermolecular monomer interactions for Helicobacter pylori VacA vacuolating activity. Mol Microbiol. 2002, 43: 1243-1253. 10.1046/j.1365-2958.2002.02818.x.View ArticlePubMedGoogle Scholar
- McClain MS, Cover TL: Expression of Helicobacter pylori vacuolating toxin in Escherichia coli. Infect Immun. 2003, 71: 2266-2271. 10.1128/IAI.71.4.2266-2271.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- McClain MS, Iwamoto H, Cao P, Vinion-Dubiel AD, Li Y, Szabo G, Shao Z, Cover TL: Essential role of a GXXXG motif for membrane channel formation by Helicobacter pylori vacuolating toxin. J Biol Chem. 2003, 278: 12101-12108. 10.1074/jbc.M212595200.View ArticlePubMedGoogle Scholar
- Vinion-Dubiel AD, McClain MS, Cao P, Mernaugh RL, Cover TL: Antigenic diversity among Helicobacter pylori vacuolating toxins. Infect Immun. 2001, 69: 4329-4336. 10.1128/IAI.69.7.4329-4336.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Vinion-Dubiel AD, McClain MS, Czajkowsky DM, Iwamoto H, Ye D, Cao P, Schraw W, Szabo G, Blanke SR, Shao Z: A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J Biol Chem. 1999, 274: 37736-37742. 10.1074/jbc.274.53.37736.View ArticlePubMedGoogle Scholar
- Schraw W, Li Y, McClain MS, Goot van der FG, Cover TL: Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J Biol Chem. 2002, 277: 34642-34650. 10.1074/jbc.M203466200.View ArticlePubMedGoogle Scholar
- Cao P, McClain MS, Forsyth MH, Cover TL: Extracellular release of antigenic proteins by Helicobacter pylori. Infect Immun. 1998, 66: 2984-2986.PubMed CentralPubMedGoogle Scholar
- Cover TL, Puryear W, Perez-Perez GI, Blaser MJ: Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Infect Immun. 1991, 59: 1264-1270.PubMed CentralPubMedGoogle Scholar
- Ilver D, Barone S, Mercati D, Lupetti P, Telford JL: Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol. 2004, 6: 167-174. 10.1046/j.1462-5822.2003.00349.x.View ArticlePubMedGoogle Scholar
- Ji X, Fernandez T, Burroni D, Pagliaccia C, Atherton JC, Reyrat JM, Rappuoli R, Telford JL: Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect Immun. 2000, 68: 3754-3757. 10.1128/IAI.68.6.3754-3757.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover TL, Papini E, Rappuoli R, Telford JL, Reyrat JM: The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci USA. 1998, 95: 10212-10217. 10.1073/pnas.95.17.10212.PubMed CentralView ArticlePubMedGoogle Scholar
- Wang WC, Wang HJ, Kuo CH: Two distinctive cell binding patterns by vacuolating toxin fused with glutathione S-transferase: one high-affinity m1-specific binding and the other lower-affinity binding for variant m forms. Biochemistry. 2001, 40: 11887-11896. 10.1021/bi010065u.View ArticlePubMedGoogle Scholar
- Oliver DC, Huang G, Nodel E, Pleasance S, Fernandez RC: A conserved region within the Bordetella pertussis autotransporter BrkA is necessary for folding of its passenger domain. Mol Microbiol. 2003, 47: 1367-1383. 10.1046/j.1365-2958.2003.03377.x.View ArticlePubMedGoogle Scholar
- Junker M, Besingi RN, Clark PL: Vectorial transport and folding of an autotransporter virulence protein during outer membrane secretion. Mol Microbiol. 2009, 71: 1323-1332. 10.1111/j.1365-2958.2009.06607.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.